Rapid development of analytical methods for evaluating pandemic vaccines: a COVID-19 perspective
Open Access
- 14 October 2021
- journal article
- research article
- Published by Future Science Ltd in Bioanalysis
- Vol. 13 (24), 1805-1826
- https://doi.org/10.4155/bio-2021-0096
Abstract
Vaccines are key in charting a path out of the COVID-19 pandemic. However, development of new vaccines is highly dependent on availability of analytical methods for their design and evaluation. This paper highlights the challenges presented in having to rapidly develop vaccine analytical tools during an ongoing pandemic, including the need to address progressive virus mutation and adaptation which can render initial assays unreliable or redundant. It also discusses the potential of new computational modeling techniques to model and analyze key viral proteins and their attributes to assist vaccine production and assay design. It then reviews the current range of analytical tools available for COVID-19 vaccine application, ranging from in vitro assays for immunogen characterization to assays to measure vaccine responses in vivo. Finally, it provides a future perspective for COVID-19 vaccine analytical tools and attempts to predict how the field might evolve over the next 5–10 years.Keywords
This publication has 151 references indexed in Scilit:
- Immunization with SARS Coronavirus Vaccines Leads to Pulmonary Immunopathology on Challenge with the SARS VirusPLOS ONE, 2012
- A Double-Inactivated Severe Acute Respiratory Syndrome Coronavirus Vaccine Provides Incomplete Protection in Mice and Induces Increased Eosinophilic Proinflammatory Pulmonary Response upon ChallengeJournal of Virology, 2011
- Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNANucleic Acids Research, 2011
- Immunodominance of HLA-A2-Restricted Hepatitis C Virus-Specific CD8 + T Cell Responses Is Linked to Naïve-Precursor FrequencyJournal of Virology, 2011
- Novel application of Ki67 to quantify antigen-specific in vitro lymphoproliferationJournal of Immunological Methods, 2010
- High Throughput T Epitope Mapping and Vaccine DevelopmentJournal of Biomedicine and Biotechnology, 2010
- Control of Immunity by the TNFR-Related Molecule OX40 (CD134)Annual Review of Immunology, 2010
- Tricks with tetramers: how to get the most from multimeric peptide–MHCImmunology, 2009
- Global trends in emerging infectious diseasesNature, 2008
- Sensitivity and specificity of tritiated thymidine incorporation and ELISPOT assays in identifying antigen specific T cell immune responsesBMC Immunology, 2007